PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit Looks Back at Pancreatic Cancer in 2025: A Year of Progress, ...

NEW — Today is One Voice Against Cancer’s Day of Action — Join Us! Today, PanCAN will join other leading patient advocacy organizations across the country for One Voice Against Cancer’s (OVAC) Day of ...

Sue Popik, a pancreatic cancer survivor and member of PanCAN’s Volunteer Advisory Council (VAC), shares her thanks for PanCAN ...

With federal research budgets facing growing uncertainty, PanCAN remains committed to building a research ecosystem to ...

One of PanCAN’s key strategies to accelerate progress for patients with pancreatic cancer is to increase the federal research funding available to researchers around the country. Since 1999, we and ...

PanCAN and our national grassroots community of advocates led the charge to create the first ever source of federal funding dedicated to pancreatic cancer, and in FY20 Congress created the Pancreatic ...

Pancreatic tumors are either exocrine or neuroendocrine (endocrine) tumors. This is based on the type of cell they start in. Knowing the type of tumor is important because each type acts differently ...

What are the symptoms of pancreatic cancer? Pancreatic cancer may cause only vague symptoms that could be confused with many other abdominal or gastrointestinal issues. It’s important to listen to ...

We accelerate progress by funding high-priority research and building and mentoring our community of researchers. Enrich a patient’s life and in turn, yours. When you make a gift, you are taking bold ...

Pancreatic neuroendocrine tumors (pancreatic NETs or PNETs) account for around 8%* of all pancreatic tumors. They may be benign or malignant and they tend to grow slower than exocrine tumors. They ...

Can Pancreatic Cancer Be Caught Early? Pancreatic cancer is hard to diagnose early. There is no standard diagnostic tool or established early detection method for pancreatic cancer in the general ...